SEI Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History

SEI Trust Company’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$90.6M	Sell	251,305 -18,338	-7%	-$6.15M	0.88%	11
2014 Q2	$76.2M	Sell	269,643 -36,739	-12%	-$10.9M	0.73%	18
2014 Q1	$92M	Sell	306,382 -19,612	-6%	-$6.04M	0.92%	11
2013 Q4	$89.7M	Buy	325,994 +41,569	+15%	+$12M	0.85%	18
2013 Q3	$89M	Buy	284,425 +39,904	+16%	+$10.5M	0.98%	10
2013 Q2	$55M	Buy	+244,521	New	+$56.9M	0.67%	20

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SEI Trust Company's REGN Position: Q3 2014 in Review

SEI Trust Company reduced its Regeneron Pharmaceuticals (REGN) stake by 6.8% in Q3 2014, selling an estimated $6.15M and leaving 251,305 shares worth $90.6M. The position accounts for 0.88% of the portfolio, ranked #11.

SEI Trust Company first reported a position in REGN in Q2 2013 and has held it in 6 quarters since. The position peaked at $92M in Q1 2014. 474 funds tracked by Wall St. Rank hold REGN as of Q3 2014.

SEI Trust Company held 251,305 shares of Regeneron Pharmaceuticals worth $90.6M as of Q3 2014.
SEI Trust Company sold 18,338 Regeneron Pharmaceuticals shares in Q3 2014, an estimated $6.15M.
Regeneron Pharmaceuticals made up 0.88% of SEI Trust Company's portfolio in Q3 2014, its #11 holding.
SEI Trust Company first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
SEI Trust Company's Regeneron Pharmaceuticals position peaked at $92M in Q1 2014.
474 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.